INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 15, 2003 |
Director, Chief Exec Officer & President
Trans History: 442
|
Director, Chief Exec Officer & President | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,384 | -- | 250,000 |
| Dec 15, 2003 |
Director, Chief Exec Officer & President
Trans History: 442
|
Director, Chief Exec Officer & President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,384 | -- | 15,384 |
| Dec 15, 2003 |
Director, Chief Exec Officer & President
Trans History: 442
|
Director, Chief Exec Officer & President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 234,616 | -- | 234,616 |
| Dec 15, 2003 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,977 | -- | 17,441 |
| Dec 15, 2003 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,692 | -- | 7,692 |
| Dec 15, 2003 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 92,308 | -- | 92,308 |
| Dec 15, 2003 |
Director
Trans History: 742
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 312,500 | -- | 312,500 |
| Dec 15, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,277 | -- | 64,817 |
| Dec 15, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,692 | -- | 7,692 |
| Dec 15, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 192,308 | -- | 192,308 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.